RE: Presentation31 Oct 2019 10:40
From 18:28 - Genomic Health Data Platform valuation
"In terms of the valuation, we estimate that each patient is valued at about £5,000 per dataset. We aim to collect 10,000 patient records over the next 2 years....The value of that nominal database at 10,000 datasets is £50 million. Now that assumes a linear 1:1 pharma access looking at that data, but in fact this is a pretty competitive database, so non-exclusive multiple pharma parties can be looking at this data in parallel. So the value of this 10,000 datasets is actually many multiples of £50 million. So we're very excited..."